An open-label, phase II study of the safety and tolerability of pirfenidone in patients with scleroderma-associated interstitial lung disease: The LOTUSS trial

Dinesh Khanna, Carlo Albera, Aryeh Fischer, Nader Khalidi, Ganesh Raghu, Lorinda Chung, Dan Chen, Elena Schiopu, Margit Tagliaferri, James R. Seibold, Eduard Gorina

Research output: Contribution to journal › Article › peer-review

208 Scopus citations

Fingerprint

Dive into the research topics of 'An open-label, phase II study of the safety and tolerability of pirfenidone in patients with scleroderma-associated interstitial lung disease: The LOTUSS trial'. Together they form a unique fingerprint.

Medicine & Life Sciences